GlassScriptPhysician profile
Russell W Cournoyer
NPI 1427030378
$724.71
in general payments reported to CMS, 2019-2025
8 companies · $257 in 2025
The $257 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2022: $118 · 2023: $87.74 · 2024: $98.84 · 2025: $257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $443.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $216.90 | 2022-2024 | Apligraf |
| Avita Medical Americas, LLC | $136.87 | 2025 | Cohealyx, Permeaderm, Recell |
| Mimedx Group, INC. | $119.92 | 2025 | |
| Abbvie INC. | $87.74 | 2023 | Dalvance |
| Integra Lifesciences Corporation | $83.49 | 2019 | |
| Wright Medical Technology, INC. | $42.71 | 2019 | |
| Kerecis Limited | $18.92 | 2019 | |
| Medartis INC. | $18.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Russell Cournoyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.